Lucy Therapeutics
Cambridge, US · Founded 2017
Biotech
Founders & leadership
AR
Amy RipkaExecutive Officer, Director
AD
Ann DeWittDirector
JR
John RippleDirector
Reported raises · per SEC filings
Form D private placements$10.6MraisedMay 2024 · 6 investors · Pharmaceuticals
Rule 506(b)$15MraisedJan 2022 · 5 investors · Pharmaceuticals
Rule 506(b)$3MraisedJul 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.